Sagimet Biosciences Ownership | Who Owns Sagimet Biosciences?
Sagimet Biosciences Ownership Summary
Sagimet Biosciences is owned by 5.86% institutional investors, 12.07% insiders, and 82.07% retail investors. Woodline partners lp is the largest institutional shareholder, holding 4.66% of SGMT shares.
SGMT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Sagimet Biosciences | 5.86% | 12.07% | 82.07% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Woodline partners lp | 1.50M | 4.66% | $10.30M |
| Blue owl capital lp | 1.33M | 4.13% | $9.11M |
| Vanguard group | 1.20M | 3.74% | $8.25M |
| Baker bros. advisors lp | 953.00K | 2.96% | $6.54M |
| Hhlr advisors | 724.80K | 2.25% | $4.97M |
| Siren | 724.77K | 2.25% | $4.97M |
| Blackrock funding, inc. /de | 612.72K | 1.90% | $4.20M |
| Schonfeld strategic advisors | 523.77K | 1.63% | $3.59M |
| Affinity asset advisors | 350.00K | 1.09% | $2.40M |
| Readystate asset management lp | 325.36K | 1.01% | $2.23M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Dumac | 75.00K | 3.59% | $571.50K |
| Blue owl capital lp | 1.33M | 2.83% | $9.11M |
| Fny investment advisers | 86.74K | 0.28% | $660.00K |
| Affinity asset advisors | 350.00K | 0.21% | $2.40M |
| Siren | 724.77K | 0.19% | $4.97M |
| Hhlr advisors | 724.80K | 0.12% | $4.97M |
| Readystate asset management lp | 325.36K | 0.10% | $2.23M |
| Quest partners | 117.26K | 0.05% | $804.40K |
| Gsa capital partners llp | 85.25K | 0.05% | $585.00K |
| Woodline partners lp | 1.50M | 0.05% | $10.30M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Schonfeld strategic advisors | 523.77K | 0.02% | 430.64K |
| Affinity asset advisors | 350.00K | 0.21% | 350.00K |
| Renaissance | 161.40K | 0.00% | 130.50K |
| Blackrock funding, inc. /de | 612.72K | 0.00% | 129.63K |
| Quest partners | 117.26K | 0.05% | 117.26K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nea management company | - | - | -2.00M |
| Point72 asset management | - | - | -1.76M |
| Alyeska investment group | - | - | -1.19M |
| Woodline partners lp | 1.50M | 0.05% | -1.05M |
| Rock springs capital management lp | - | - | -787.81K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Affinity asset advisors | 350.00K | 0.21% | 350.00K | $2.40M |
| Quest partners | 117.26K | 0.05% | 117.26K | $804.40K |
| Graham capital management | 49.05K | 0.01% | 49.05K | $336.49K |
| Man group | 46.95K | 0.00% | 46.95K | $322.05K |
| Squarepoint ops | 35.06K | 0.00% | 35.06K | $240.55K |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -10.00 |
| Hollencrest capital management | -15.00 |
| Proffitt & goodson | -175.00 |
| Ifp advisors | -1.00K |
| Riggs asset managment | -1.02K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 21 | -69.12% | 1,885,710 | -83.19% | 5 | 0.48% | 8 | -77.78% | 2 | -77.78% |
| Jun 30, 2025 | 73 | -2.67% | 11,674,800 | -15.26% | 36 | 1.98% | 38 | 15.15% | 11 | -38.89% |
| Mar 31, 2025 | 6 | -91.43% | 2,545,717 | -85.38% | 7 | 0.26% | 1 | -96.77% | 1 | -94.74% |
| Dec 31, 2024 | 71 | 5.97% | 17,500,774 | -10.97% | 55 | 1.49% | 32 | 39.13% | 19 | -17.39% |
| Sep 30, 2024 | 67 | -20.24% | 19,656,790 | -6.06% | 61 | 1.42% | 23 | -46.51% | 23 | 4.55% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 20, 2025 | Kemble George | Executive Chairman | Sell | $289.98K |
| Jul 21, 2025 | Happel David | President & CEO | Sell | $598.12K |
| Jul 21, 2025 | Martins Eduardo Bruno | Chief Medical Officer | Sell | $75.61K |
| Jul 21, 2025 | Rozek Elizabeth | General Counsel and CCO | Sell | $98.47K |
| Jul 23, 2024 | Kemble George | Executive Chairman | Sell | $74.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 1 |
| 2025 Q3 | - | 3 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q3 | - | 4 |
SGMT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools